Story · Medicine & Biotech

Medtronic studying safety, effectiveness of its self-expanding TAVR valves in patients with moderate AS

1 outlet · first reported by Cardiovascular Business on

This represents the first randomized trial focused on treating moderate aortic stenosis with Medtronic's self-expanding, supra-annular Evolut platform. (Cardiovascular Business)

Coverage, in order

  1. Cardiovascular Business indie randomized trial
    Medtronic studying safety, effectiveness of its self-expanding TAVR valves in patients with moderate AS

    This represents the first randomized trial focused on treating moderate aortic stenosis with Medtronic's self-expanding, supra-annular Evolut platform.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.